Fortis Malar Hospitals Reports Negative Financial Results for Q4 2023

Fortis Malar Hospitals, a microcap healthcare services company, recently announced its financial results for the quarter ending December 2023. The company's stock has been given a 'Strong Sell' call by MarketsMOJO. According to the financials, Fortis Malar has seen a negative performance in the quarter, with a score of -15 compared to -4 in the previous three months. However, there are some positive aspects to the company's financials. The company's cash and cash equivalents for the half-yearly period were at their highest in the last six periods, at Rs 29.77 crore. This indicates an improvement in short-term liquidity. On the other hand, there are some areas that are not working in Fortis Malar's favor based on the December 2023 financials. The company's profit before tax less other income (PBT) for the quarter was at Rs -5.26 crore, a decrease of 36.3% compared to the average PBT of the previous four quarters. This shows a very negative trend in the near term. Similarly, the company's profit after tax (PAT) for the quarter was at Rs -4.00 crore, a decrease of 24.4% compared to the average PAT of the previous four quarters. The net sales for the quarter were also down by 10.4% compared to the average net sales of the previous four quarters. The company's ability to manage interest payments has also deteriorated, with the operating profit to interest ratio at its lowest in the last five quarters. The net sales and operating profit for the quarter were also at their lowest in the last five quarters, indicating a negative trend. Furthermore, the company's operating profit margin for the quarter was at -6.20%, the lowest in the last five quarters, showing a decline in efficiency. The PBT for the quarter was also at its lowest in the last five quarters, indicating a negative trend in the near term. Overall, Fortis Malar's financial performance for the quarter ending December 2023 has been negative, with some areas showing improvement while others are facing challenges. Investors should carefully consider these factors before making any decisions regarding the company's stock.